about
Pulmonary hypertension in chronic lung diseasesPulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthmaA systems biology approach reveals a link between systemic cytokines and skeletal muscle energy metabolism in a rodent smoking model and human COPD.Survival in pulmonary hypertension in Spain: insights from the Spanish registry.Chromosomal bands affected by acute oil exposure and DNA repair errors.Pulmonary hypertension in chronic obstructive pulmonary disease.Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation.Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig.Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.Inflammation, growth factors, and pulmonary vascular remodeling.Pulmonary hypertension due to left heart diseases.Management of Pulmonary Hypertension in Patients with Chronic Lung Disease.Plasticity of CD133+ cells: role in pulmonary vascular remodeling.Prolonged respiratory symptoms in clean-up workers of the prestige oil spill.Pneumocystis pneumonia in HIV antibody positive patients.Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats.Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.Pulmonary gas exchange responses to histamine and methacholine challenges in mild asthma.Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma.Evaluation of the persistence of functional and biological respiratory health effects in clean-up workers 6 years after the prestige oil spill.Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease.Undetected viral infection in diffuse alveolar damage associated with bone marrow transplantation.Clinical research in pulmonary hypertension comes of age.Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.Formoterol protects against platelet-activating factor-induced effects in asthma.Endurance exercise training improves heart rate recovery in patients with COPD.Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension.Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.Physical activity in COPD patients: patterns and bouts.Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey.Pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia.Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.Pregnancy outcomes in pulmonary arterial hypertension in the modern management era.Chronic obstructive pulmonary disease: a disease of the endothelium?Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD.Expression of BK(Ca) channels in human pulmonary arteries: relationship with remodeling and hypoxic pulmonary vasoconstriction.
P50
Q26999693-6829752C-FEE8-4721-8DA9-72B7C9056BDCQ28292353-AD2F9766-65AB-46FA-85E6-60527D55210FQ34193524-0624E7D3-1C92-41BE-85F0-1FCF77DEC0C4Q34256703-0CC00FC4-A4B7-4464-B43F-4BD21A2055D1Q35058557-8E5481B2-70AB-46E9-8364-BA3579C5173EQ35135327-3A7E8016-4292-4853-89A5-ED1035B3EF40Q35180258-F497E4DC-F14C-4E7D-AD98-BDFF48559CE7Q35574283-9BAC25CA-4948-4EBA-9CD1-527F518FBBAAQ35803369-97CB201D-9743-4CB5-8922-460119355540Q37523851-7F8411B2-1652-4931-A91A-3F34291D0FC6Q37531255-85B71930-C4C3-4DE0-A3D6-AA442C7071C8Q38172722-248E4F6E-CCFA-4162-BD6E-05AE51A95607Q38538687-309B634F-B7E0-4DD0-8F20-A358668DB781Q40081995-1905BBBA-8198-4A1E-B9FC-BB7EC2F0C4E2Q42009693-352205FC-FE13-41B1-851D-B5BB70AF4371Q42415425-4EEED8BC-31B6-43B4-9C22-E37C0E4239D6Q43078753-2BF8B481-EAA2-4F59-8FAA-05B2D1AB0AD8Q43088310-1D993089-42B2-48D7-8D38-67BD3AEC2596Q43139838-3521679E-AD5C-4498-BD6A-A90A3F9A01B0Q43252197-5EE3CEE3-BEE7-459B-A2AB-A999747AAD20Q43636232-D6FDD362-3981-4129-A984-2B8FFB5A1748Q44006013-D78F1056-D98F-4025-A84F-BA769C339CFEQ44147644-770010DF-733C-4393-B87A-E4DECCDE1C52Q44162536-698B4781-E47B-4194-883E-3787994F9A3CQ44200531-7380141E-A6A6-4D53-ACE1-A77B75D93ADFQ44220020-3866E453-125F-41BA-86E4-CF44441FDA20Q44406271-D1ACDF2B-649D-4482-A611-34B77580528FQ44738187-E03B350A-E208-4C6F-AA97-BE763BE0309CQ44749073-17CE0630-7F75-4D51-A056-EDCEC8894B19Q44787584-E31D210B-99D6-4A56-8266-4593F2E4414AQ44966770-0313F33E-0028-4839-9F59-68EB9329379AQ45752492-318F0FDF-1FB6-4568-9743-6E45F2850018Q45810966-BCFDAFAA-FE71-4BD5-93B8-52150584433BQ45857044-90A3FC01-BEE2-4A2B-8F68-20B82601F5E0Q45964729-670FA014-50F0-4075-AB4E-5C342927E014Q45973918-2441F178-E9BA-412A-A4DB-A57B98D502EEQ46325114-787B3461-11D5-4DFE-B258-5E6B8CB1D5F1Q46329191-7464B547-8532-4608-B1F3-B7FA38CBACB5Q46331224-719284A7-516E-4E86-AD28-F64A869DD598Q46414115-F0F53FFB-A3CA-4B66-9FE4-9DCA9EB452DE
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Joan Albert Barberà
@ast
Joan Albert Barberà
@en
Joan Albert Barberà
@es
Joan Albert Barberà
@nl
Joan Albert Barberà
@sl
type
label
Joan Albert Barberà
@ast
Joan Albert Barberà
@en
Joan Albert Barberà
@es
Joan Albert Barberà
@nl
Joan Albert Barberà
@sl
prefLabel
Joan Albert Barberà
@ast
Joan Albert Barberà
@en
Joan Albert Barberà
@es
Joan Albert Barberà
@nl
Joan Albert Barberà
@sl
P214
P244
P950
P106
P1153
7102961833
P1580
P21
P213
0000 0003 8330 903X
P214
P244
nb2010006903
P31
P496
0000-0003-1469-4990
P735
P7859
lccn-nb2010006903